Tomato lycopene and inflammatory cascade: Basic interactions and clinical implications

Current Medicinal Chemistry

Volumn 17, Issue 23, 2010, Pages 2547-2563

  Palozza, P ^a   Parrone, N ^a   Catalano, A ^a   Simone, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

cytokines; in vitro studies; in vivo studies; inflammation; Lycopene; redox sensitive molecular pathways; ROS; tomato tomato products

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BETA CRYPTOXANTHIN; CAROTENE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOXYGENASE; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; XANTHOPHYLL; ZEAXANTHIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL DEATH; CHEMICAL REACTION; COLITIS; DOWN REGULATION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPID OXIDATION; LIPID PEROXIDATION; NONHUMAN; PROSTATITIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TOMATO; VIRUS INFECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTENOIDS; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LYCOPERSICON ESCULENTUM; PHYTOTHERAPY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77955614681     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791556041     Document Type: Article

References (181)

1. Driscoll, K.E.; Carter, J.M.; Hassenbein, D.G.; Howard, B. Cytokines and particle-induced inflammatory cell recruitment. Environ. Health Perspect., 1997, 105, 1159-1164.
2. Uauy, R.; Kain, J.; Mericq, V.; Rojas, J.; Corvalán, C. Nutrition, child growth, and chronic disease prevention. Ann. Med., 2008, 40, 11-20.
3. Rao, A.V.; Agarwal, S. Role of antioxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr., 2000, 19, 563-569.
4. Stahl, W.; Sies, H. Lycopene. a biologically important carotenoid for humans? Arch. Biochem. Biophys., 1996, 336, 1-9.
5. Clinton, S.K. Lycopene. chemistry, biology, and implications for human health and disease. Nutr. Rev., 1998, 1, 35-51.
6. Agarwal, S.; Rao, A.V. Carotenoids and chronic diseases. Drug Metab. Drug Interact., 2000, 17, 189-210.
7. Agarwal, A.; Shen, H.; Agarwal, S.; Rao, A. Lycopene content of tomato products. its stability, bioavailability and in vivo antioxidant properties. J. Med. Food, 2001, 4, 9-15.
8. Chasse, G.A.; Mak, M.L.; Deretey, E.; Farkas, I.; Torday, L.L.; Papp, J.G.; Sarma, D.S.R.; Agarwal, A.; Chakravarthi, S.; Agarwal, S.; Rao, A.V. An ab initio computational study on selected lycopene isomers. J. Mol. Struc. Theochem., 2001, 571, 27-37.
9. Rao, A.V.; Ray, M.R.; Rao, L.G. Lycopene. Adv. Food Nutr. Res., 2006, 51, 99-64.
10. Gärtner, C.; Stahl, W.; Sies, H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr., 1997, 66, 116-122.
11. Stahl, W.; Sies, H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr., 1992, 122, 2161-2166.
12. Gustin, D.M.; Rodvold, K.A.;. Sosman, J.A.; Diwadkar-Navsariwala, V.; Stacewicz-Sapuntzakis, M.; Viana, M.; Crowell, J.A.; Murray, J.; Tiller, P.; Bowen, P.E. Single-dose pharmacokinetic study of lycopene delivered in a welldefined food-based lycopene delivery system (tomato pasteoil mixture) in healthy adult male subjects. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 850-860.
13. Van Breemen, R.B.; Xu, X.; Viana, M.A.; Chen, L.; Stacewicz-Sapuntzakis, M.; Duncan, C.; Bowen, P.E.; Sharifi, R. Liquid chromatography-mass spectrometry of cis - and all-trans -lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce. J. Agric. Food Chem., 2002, 50, 2214-2219.
14. Zaripheh, S.; Erdman Jr. J.W. The biodistribution of a single oral dose of [14C]-lycopene in rats prefed either a control or lycopenerich diet., J. Nutr., 2005, 135, 2212-2218.
15. Liu, A.; Pajkovic, N.; Pang, Y.; Zhu, D.; Calamini, B.; Mesecar, A.L.; van Breemen, R.B. Absorption and subcellular localization of lycopene in human prostate cancer cells. Mol. Cancer Ther., 2006, 5, 2879-2885.
16. Khachik, F.; Carvallo, L.; Bernstein, P.S.; Muir, G.J.; Zhao, D.Y.; Katz, N.B. Chemistry, distribution and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med., 2002, 227, 845-851.
17. Khachik, F.; Spangler, C.J.; Smith Jr, J.C; Canfield, L.M.; Steck, A.; Pfander, H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem., 1997, 69, 1873-1881.
18. Bignotto, L.; Rocha, J.; Sepodes, B.; Eduardo-Figueira, M.; Pinto, R.; Chaud, M.; de Carvalho, J.; Moreno, H.; Mota-Filipe, H. Antiinflammatory effect of lycopene on carrageenan-induced paw oedemaand hepatic ischaemia-reperfusion in the rat. Br. J. Nutr., 2009, 10, 1-8.
19. Han, C.H.; Yang, C.H.; Sohn, D.W.; Kim, S.W.; Kang, S.H.; Cho, Y.H. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model. Int. J. Antimicrob. Agents., 2008, 31, 102-107.
20. Reifen, R.; Nur, T.; Matas, Z.; Halpern, Z. Lycopene supplementation attenuates the inflammatory status of colitis in a rat model. Int. J. Vitam. Nutr. Res., 2001, 71, 347-351.
21. Reifen, R.; Nissenkorn, A.; Matas, Z.; Bujanover, Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J. Gastroenterol., 2004, 39, 514-519.
22. Lee, C.M.; Chang, J.H.; Moon, D.O.; Choi, Y.H.; Choi, I.W.; Park, Y.M.; Kim, G.Y. Lycopene suppresses ovalbumin-induced airway inflammation in a murine model of asthma. Biochem. Biophys. Res. Commun., 2008, 374, 248-252.
23. Zhou, C.; Han, W.; Zhang, P.; Cai, M.; Wei, D.; Zhang, C. Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr. Res., 2008, 28, 122-130.
24. Hu, M.Y.; Li, Y.L.; Jiang, C.H.; Liu, Z.Q.; Qu, S.L.; Huang, Y.M. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition., 2008, 24, 1030-1038.
25. Salvemini, D.; Wang, Z.Q.; Wyatt, P.S.; Bourdon, D.M.; Marino, M.H.; Manning, P.T.; Currie, M.G. Nitric oxide. a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol., 1996, 118, 829-838.
26. Cuzzocrea, S.; Zingarelli, B.; Gilad, E.; Hake, P.; Salzman, A.L.; Szabó, C. Protective effect of melatonin in carrageenan-induced models of local inflammation. relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal. Res., 1997, 23, 106-116.
27. Fridovich, I. The biology of oxygen radicals. Science, 1978, 201, 875-880.
28. Chance, B.; Sies, H.; Boveris, A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev., 1979, 59, 527-605.
29. Deby, C.; Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Biochem. Pharmacol., 1990, 39, 399-405.
30. Wenli, Y.; Yaping, Z. Chemiluminescence evaluation of oxidative damage to biomolecules induced by singlet oxygen and the protective effects of antioxidants. Biochim. Biophys. Acta., 2005, 1725, 30-34.
31. Foote, C.S.; Denny, R.W. Chemistry of singlet oxygen. VIII. Quenching by b-Carotene. J. Am. Chem. Soc., 1968, 90, 6233-6235.
32. Tsen, K.T.; Tsen, S.W.; Kiang J.G. Lycopene is more potent than beta carotene in the neutralization of singlet oxygen. role of energy transfer probed by ultrafast Raman spectroscopy. J. Biomed. Opt., 2006, 11, 064025.
33. Krinsky, N.I.; Johnson, E.J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med., 2005, 26, 459-416.
34. Galano, A. Relative antioxidant efficiency of a large series of carotenoids in terms of one electron transfer reactions. J. Phys. Chem. B., 2007, 111, 12898-12908.
35. Mortensen, A.; Skibsted, L.H. Relative stability of carotenoid radical cations and homologue tocopheroxyl radicals. A real time kinetic study of antioxidant hierarchy. FEBS Lett., 1997, 417, 261-266.
36. Mortensen, A.; Skibsted, L.H.; Willnow, A.; Everett, S.A. Reappraisal of the tocopheroxyl radical reaction with b-carotene. evidence for the oxidation of vitamin E by the b-carotene radical cation. Free Rad. Res., 1997, 28, 69-80.
37. Mortensen, A.; Skibsted L.H.; Truscott T.G. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys., 2001, 385, 13-19.
38. Ferreira, A.L.; Yeum, K.J.; Russell, R.M.; Krinsky, N.I.; Tang, G. Enzymatic and oxidative metabolites of lycopene. J. Nutr. Biochem., 2004, 15, 493-502.
39. Nagao, A. Oxidative conversion of carotenoids to retinoids and other products. J. Nutr., 2004, 134, 237S-240S.
40. Biacs, P.A.; Daood, H.G. Lipoxygenase-catalysed degradation of carotenoids from tomato in the presence of antioxidant vitamins. Biochem. Soc. Trans., 2000, 28, 839-845.
41. Keisari, Y.; Braun, L.; Flescher, E. The oxidative burst and related phenomena in mouse macrophages elicited by different sterile inflammatory stimuli. Immunobiology, 1983, 165, 78-89.
42. Lander, H.M.; Hajjar, D.P.; Hempstead, B.L.; Mirza, U.A.; Chait, B.T.; Campbell, S.; Quilliam, L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem., 1997, 272, 4323-4326.
43. Nathan, C.F.; Root, R.K. Hydrogen peroxide release from mouse peritoneal macrophages. dependence on sequential activation and triggering. J. Exp. Med., 1977, 146, 1648-1662.
44. Dinauer, M.C.; Deck, M.B.; Unanue, E.R. Mice lacking reduced nicotinamide adenine dinucleotide phosphate oxidase activity show increased susceptibility to early infection with Listeria monocytogenes. J. Immunol., 1997, 158, 5581-5583.
45. Endres, R.; Luz, A.; Schulze, H.; Neubauer, H.; Fütter, A.; Holland, S.M.; Wagner, H.; Pfeffer, K. Listeriosis in p47phox2/2 and TRp552/2 mice. protection despite absence of ROI and susceptibility despite presence of RNI. Immunity, 1997, 7, 419-432.
46. Hampton, M.B.; Kettle, A.J.; Winterbourn, C.C. Inside the neutrophil phagosome. oxidants, myeloperoxidase, and bacterial killing. Blood, 1998, 92, 3007-3017.
47. Schoonbroodt, S.; Legrand-Poels, S.; Best-Belpomme, M.; Piette, J. Activation of the NF-kB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J., 1997, 321, 777-785.
48. Bonizzi, I.G.; Piette, J.; Merville, M.P.; Bours, V. Cell typespecific role for reactive oxygen species in nuclear factor kB activation by interleukin-1. Biochem. Pharmacol., 2000, 59, 07-11.
49. Tauber, A.I.; Borregaard, N.; Simons, E.; Wright, J. Chronic granulomatous disease. a syndrome of phagocyte oxidase deficiencies. Medicine, 1983, 62, 286-309.
50. Leusen, J.H.W.; De K.A.; Hilarius P.M.; Ahlin, A.; Palmblad, J.; Smith, C.I.; Diekmann, D.; Hall, A.; Verhoeven, A.J.; Roos, D. Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J. Exp. Med., 1996, 184, 1243-1249.
51. Walrand, S.; Farges, M.C.; Dehaese, O.; Cardinault, N.; Minet-Quinard, R.; Grolier, P.; Bouteloup-Demange, C.; Ribalta, J.; Winklhofer-Roob, B.M.; Rock, E.; Vasson, M.P. In vivo and in vitro evidences that carotenoids could modulate the neutrophil respiratory burst during dietary manipulation. Eur. J. Nutr., 2005, 44, 114-120.
52. Tatsuzawa, H.; Maruyama, T.; Misawa, N.; Fujimori, K.; Nakano, M. Quenching of singlet oxygen by carotenoids produced in escherichia coli-attenuation of singlet oxygen-mediated bacterial killing by carotenoids. FEBS Lett., 2000, 484, 280-284.
53. 2) as the principal oxidant in myeloperoxidasemediated bacterial killing in neutrophil phagosome. Biochem. Biophys. Res. Commun., 1999, 262, 647-650.
54. Palmer, R.M.J.; Rees, D.D.; Ashton, D.S.; Moncada, S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation. Biochem. Biophys. Res. Commun., 1988, 153, 1251-1256.
55. Stamler, J.S.; Single, D.; Loscalzo, J. Biochemistry of nitric oxide and its redox-activated forms. Science, 1992, 258, 1898-1902.
56. Gow, A.J.; Stamler, J.S. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature, 1998, 391, 169-173.
57. Bredt, D.S.; Hwang, P.M.; Glatt, C.E.; Lowenstein, C.; Reed, R.R.; Synder, S.H. 450 Reductase. Nature, 1991, 351, 714-718.
58. Xie, Q.W.; Cho, H.J.; Calayacay, J.; Mumford, R.A.; Swiderek, K.M.; Lee, T.D.; Ding, A.; Troso, T.; Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 1992, 256, 225-228.
59. Lamas, S.; Marsden, P.A.; Li, G.K.; Tempst, P.; Michel, T. Endothelial nitric oxide synthase. molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA, 1992, 89, 6348-6352.
60. Bogdan, C.; Röllinghoff, M.; Diefenbach, A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol., 2000, 12, 64-76.
61. Macmicking, J.; Xie, Q.W.; Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol., 1997, 15, 323-350.
62. Tuomisto, T.T.; Korkeela, A.; Rutanen, J.; Viita, H; Bräsen, J.H.; Riekkinen, M.S.; Rissanen, T.T.; Karkola, K.; Kiraly, Z.; Kölble, K.; Ylä-Herttuala, S. Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array. overexpression of HMGCoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and interleukin receptors. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 2235-2240.
63. Pollock, J.S.; Förstermann, U.; Tracey, W.R.; Nakane, M. Nitric oxide synthase isozymes antibodies. Histochem. J., 1995, 27, 738-744.
64. Wei, L.; Hubbard, S.R.; Hendrickson, W.A.; Ellis, L. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J. Biol. Chem. 1995, 270, 8122-8130.
65. Rafi, M.M.; Yadav, P.N.; Reyes, M. Lycopene inhibits LPSinduced proinflammatory mediator inducible nitric oxide synthase in mouse macrophage cells. J. Food Sci., 2007, 72, 69-74.
66. Hughes, D.A.; Wright, A.J.; Finglas, P.M.; Polley, A.C.; Bailey, A.L.; Astley, S.B.; Southon, S. Effects of lycopene and lutein supplementation on the expression of functionally associated surface molecules on blood monocytes from healthy male nonsmokers. J. Infect. Dis., 2000, 182, 11-15.
67. Böhm, F.; Edge, R.; Burke, M.; Truscott, T.G. Dietary uptake of lycopene protects human cells from singlet oxygen and nitrogen dioxide - ROS components from cigarette smoke. Photochem. Photobiol. B., 2001, 64, 176-178.
68. Feng, Xia L.Y.; Garcia, G.E.; Hwang, D.; Wilson, C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J. Clin. Invest., 1995, 95, 1669-1675.
69. Munroe, D.G.; Wang, E.Y.; MacIntyre J.P.; Tam, S.S.C.; Lee, D.H.S.; Taylor, G.R.; Zhou, L.; Plante, R.K.; Kazmi, S.M.I.; Baeuerle, P.A.; Lau, C.Y. Novel intracellular signalling function of prostaglandin H synthase-1 in NF-kB activation. J. Inflamm., 1995, 45, 260-268.
70. Goulet, J.L.; Snouwaert, J.N.; Latour, A.M.; Coffman, T.M.; Koller, B.H. Altered inflammatory responses in leukotrienedeficient mice. Proc. Natl. Acad. Sci. USA, 1994, 91, 12852-12856.
71. Corella, D.; González, J.I.; Bulló, M.; Carrasco, P.; Portolés, O.; Díez-Espino, J.; Covas, M.I.; Ruíz-Gutierrez, V.; Gómez-Gracia, E.; Arós, F.; Fiol, M.; Herrera, M.C.; Santos, J.M.; Sáez, G.; Lamuela, R.; Lahoz, C.; Vinyoles, E.; Ros, E.; Estruch, R. Polymorphisms cyclooxygenase-2-765G>C and interleukin-6-174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J. Nutr., 2009, 139, 128-134.
72. De Stefano, D.; Maiuri, M.C.; Simeon, V.; Grassia, G.; Soscia, A.; Cinelli, M.P.; Carnuccio, R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ. Eur. J. Pharmacol., 2007, 566, 192-199.
73. Los, M.; Schenk, H.; Hexel, K.; Baeuerle, P.A.; Dröge, W.; Schulzeosthoff, K. IL-2 gene expression and NF-kB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J., 1995, 14, 3731-3740.
74. Yamamoto, S. Mammalian lipoxygenases. molecular structures and functions. Biochim. Biophys. Acta., 1992, 1128, 117-131.
75. Hazai, E.; Bikádi, Z.; Zsila, F.; Lockwood, S.F. Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5- lipoxygenase. Bioorg. Med. Chem., 2006, 14, 6859-6867.
76. 2. Role in cell survival following oxidant injury. J. Biol. Chem., 1996, 271, 4138-4142.
77. Hehener, S.P.; Breitkreutz, R.; Shubinsky, G.; Unsoeld, H.; Schulze-Osthoff K.; Schimtz, M.L.; Dröge, W. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J. Immunol., 2000, 165, 4319-4328.
78. Lo, Y.Y.C.; Wong, J.M.S.; Crutz, T.F. Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J. Biol. Chem., 1996, 271, 15703-15707.
79. 2- in vascular smooth muscle cells. Circ. Res., 1995, 77, 29-36.
80. Ushio-Fukai, M.; Alexander, R.W.; Akers, M.; Griendling, K.K. p38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II. role in vascular smooth muscle cell hypertrophy. J. Biol. Chem., 1998, 273, 15022-15029.
81. 2 for platelet-derived growth factor signal transduction. Science, 1995, 270, 296-299.
82. Clerk, A.; Fuller, S.J.; Michael, A.; Sugden, P.H. Stimulation of "stress-regulated" mitogen-activated protein kinases (stressactivated protein kinases/c-Jun N-terminal kinases and p38- mitogenactivated protein kinases) in perfused rat hearts by oxidative and other stresses. J. Biol. Chem., 1998, 273, 7228-7234.
83. Sarkar, F.H.; Li, Y.; Wang, Z; Kong, D. Cellular signaling perturbation by natural products. Cell Signal., 2009.
84. Agarwal, B.B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71, 1397-1421.
85. Chalabi, N.; Satih, S.; Delort, L; Bignon, Y.J.; Bernard-Gallon, D.J. Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim. Biophys. Acta., 2007, 1769, 124-130.
86. Kim, G.Y.; Kim, J.H.; Ahn, S.C.; Lee, H.J.; Moon, D.O.; Lee, C.M.; Park, Y.M. Lycopene suppresses the lipopolysaccharideinduced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-kappaB. Immunology, 2004, 113, 203-211.
87. Joo, Y.E.; Karrasch, T.; Mühlbauer, M.; Allard, B.; Narula, A.; Herfarth, H.H.; Jobin, C. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One, 2009, 4, 4562.
88. Neuzil, J.; Weber, C.; Kontush, A. The role of vitamin E in atherogenesis. linking the chemical, biological and clinical aspects of the disease. Atherosclerosis, 2001,157, 257-283.
89. Adameova, A.; Xu, Y.J.; Duhamel, T.A.; Tappia, P.S.; Shan, L.; Dhalla, N.S. Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr. Pharm. Des. 2009, 15, 3094-3107.
90. Lee, S.J.; Bai, S.K.; Lee, K.S.; Namkoong, S.; Na, H.J.; Ha, K.S.; Han, J.A.; Yim, S.V.; Chang, K.; Kwon, Y.G.; Lee, S.K.; Kim, Y.M. Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation. Mol. Cells, 2003, 16, 97-105.
91. Heiss, E.; Herhaus, C.; Klimo, K.; Bartsch, H.; Gerhauser, C. Nuclear factor κB is a molecular target for sulforaphanemediated antiinflammatory mechanisms. J. Biol. Chem., 2001, 276, 32008-32015.
92. Matsuda Moriguchi, S.T.; Koyasu, S.; Nishida, E. T-lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem., 1998, 273, 12378-12382.
93. Su, B.; Jacinto, E.; Hibi, M.; Kallunki, T.; Karin, M.; Ben-Neriah, Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell., 1994, 77, 727-736.
94. Angel, P.; Karin, M. The role of jun, fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta., 1991, 1072, 129-157.
95. Devary, Y.; Gottlieb, R.A.; Laus, L.F.; Karin, M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol., 1991, 11, 2804-2811.
96. 2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells. AP-1 as secondary antioxidant response factor. EMBO J., 1993, 12, 2005-2015.
97. Stein, B.; Rahmsdorf, H.J.; Steffen, A.; Litfin, M.; Herrlich, P. UVinduced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, cfos, and metallothionein. Mol. Cell. Biol., 1989, 9, 5169-5181.
98. Janssen, Y.M.; Matalon, S.; Mossman, B.T. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am. J. Physio.l Lung Cell. Mol. Physiol., 1997, 273, 789-796.
99. Morris, B.J. Stumulation of immediate early gene expression in striatal neurons by nitric oxide. J. Biol. Chem., 1995, 270, 24740-24744.
100. Shibanuma, M.; Kuroki, T.; Nose, K. Induction of DNA replication and expression of proto-oncogene c-myc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene, 1988, 3, 17-21.
101. Karas, M.; Amir, H.; Fishman, D.; Danilenko, M.; Segal, S.; Nahum, A.; Koifmann, A.; Giat, Y.; Levy, J.; Sharoni, Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer, 2000, 36, 101-111.
102. Bauerle, P.A.; Baltimore, D. NF-kB. ten years after. Cell, 1996, 87, 13-20.
103. Bauerle, P.A.; Henkel, T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol., 1994, 12, 141-179.
104. Schrek, R.; Bauerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-kB transcription factor and HIV-1. Trends Cell. Biol., 1991, 1, 39-42.
105. Huang, C.S.; Fan Y.E.; Lin C.Y.; Hu, M.L.; Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J. Nutr. Biochem., 2007, 18, 449-456.
106. Touyz, R.M.; Schiffrin, E.L. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul. Pharmacol., 2006, 45, 19-28.
107. Zaripheh, S.; Nara, T.Y.; Nakamura, M.T.; Erdman, J.W.Jr. Dietary lycopene downregulates carotenoid 15,159-monooxygenase and PPAR-γ in selected rat tissues. J. Nutr., 2006, 136, 932-938.
108. Campbell, J.K.; Stroud, C.K.; Nakamura, M.T.; Lila, M.A.; Erdman, J.W.Jr. Serum Testosterone Is Reduced Following Short- Term Phytofluene, Lycopene, or Tomato Powder Consumption in F344 Rats. J. Nutr., 2006, 136, 2813-2819.
109. Wyllie, A.H.; Kerr, J.F.R.; Currie, A.E. Cell death. the significance of apoptosis. Int. Rev. Cytol., 1980, 68, 251-306.
110. Banki, K.; Hutter, E.; Gonchoroff, N.J.; PERL, A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol., 1999, 162, 1466-1479.
111. Williams, M.S.; Henkart, P.A. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol., 1996, 157, 2395-2402.
112. Dumont, A.; Hehner, S.P.; Hofmann, T.G.; Ueffing, M.; Dröge, W.; Schmitz, M.L. Hydrogen peroxide-induced apoptosis is CD95- independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kB. Oncogene, 1999, 18, 747-757.
113. Palozza, P.; Simone, R.; Catalano, A.; Bonisnsegna, A.; Böhm, V.; Fröhlich, K.; Mele, M.C.; Monego, G.; Ranelletti, F.O. Lycopene prevents 7-keto-cholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J. Nutr. Biochem., 2010, 21, 34-46.
114. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys., 1989, 274, 532-538.
115. Stahl, W.; Junghans, A.; deBoer, B.; Driomina, E.S.; Briviba, K.; Sies, H. Carotenoid mixtures protect multilamellar liposomes against oxidative damage. synergistic effects of lycopene and lutein. FEBS Lett., 1998, 427, 305-308.
116. Klebanov, G.I.; Kapitanov, A.B.; Teselkin, Yu O.; Babenkova, I.V.; Zhambalova, B.A.; Lyubitsky, O.B.; Nesterova, O.A.; Vasil'eva, O.V.; Popov, I.N.; Lewin, G.; Vladimirov, YuA. The antioxidant properties of lycopene. Membr. Cell. Biol., 1998, 12, 287-300.
117. Chichili, G.R.; Nohr, D.; Frank, J.; Flaccus, A.; Fraser, P.D.; Enfissi, E.M.; Biesalski, H.K. Protective effects of tomato extract with elevated beta-carotene levels on oxidative stress in ARPE-19 cells. Br. J. Nutr., 2006, 96, 643-649.
118. Agarwal, S.; Rao, A.V. Tomato lycopene and low density lipoprotein oxidation. a human dietary intervention study. Lipids, 1998, 33, 981-984.
119. Rao, A.V. Processed tomato products as a source of dietary lycopene. bioavailability and antioxidant properties. Can. J. Diet Pract. Res., 2004, 65, 161-165.
120. Jamshidzadeh, A.; Baghban, M.; Azarpira, N.; Bardbori, A.M.; Niknahad, H. Effects of tomato extract on oxidative stress induced toxicity in different organs of rats. Food Chem. Toxicol., 2008, 46, 3612-3615.
121. Gitenay, D.; Lyan, B.; Rambeau, M.; Mazur, A.; Rock, E. Comparison of lycopene and tomato effects on biomarkers of oxidative stress in vitamin E deficient rats. Eur. J. Nutr., 2007, 46, 468-475.
122. Esterbauer, H.; Gebicki, J.; Puhl, H.; Jurgens, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med., 1992, 13, 341-390.
123. Dugas, T.R.; Morel, D.W.; Harrison, E.H. Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cellmediated oxidation of low-density lipoprotein. Free Radic. Biol. Med., 1999, 26, 1238-1244.
124. Fuhrman, B.; Volkova, N.; Rosenblat, M.; Aviram, M. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid. Redox Signal., 2000, 2, 491-506.
125. Hininger, I.A.; Meyer-Wenger, A.; Moser, U.; Wright, A.; Southon, S.; Thurnham, D.; Chopra, M.; Van Den Berg, H.; Olmedilla, B.; Favier, A.E.; Roussel, A.M. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J. Am. Coll. Nutr., 2001, 20, 232-238.
126. Lowe, G.M.; Booth, L.A.; Young, A.J.; Bilton, R.F. Lycopene and beta-carotene protect against oxidative damage in HT-29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Radic. Res., 1999, 30, 141-151.
127. Astley, S.B.; Hughes, D.A.; Wright, A.J.; Elliott, R.M.; Southon, S. DNA damage and susceptibility to oxidative damage in lymphocytes. effects of carotenoids in vitro and in vivo. Br. J. Nutr., 2004, 91, 53-61.
128. Torbergsen, A.C.; Collins, A.R. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur. J. Nutr., 2000, 39, 80-85.
129. Devaraj, S.; Mathur, S.; Basu, A.; Aung, H.H.; Vasu, V.T.; Meyers, S.; Jialal, I. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J. Am. Coll. Nutr., 2008, 27, 267-273.
130. Barton, B.E. IL-6. Insights into novel biological activities. Clin. Immunol. Immunopathol., 1997, 85, 16-20.
131. Opal, S.M.; DePalo, V.A. Anti-inflammatory cytokines. Chest., 2000, 117, 1162-72.
132. Cavaillon, J.M. Pro- versus anti-inflammatory cytokines. myth or reality. Cell. Mol. Biol., 2001, 47, 695-702.
133. Son, Y.H.; Jeong, Y.T.; Lee, K.A.; Choi, K.H.; Kim, S.M.; Rhim, B.Y.; Kim, K. Roles of MAPK and NF-kappaB in interleukin-6 induction by lipopolysaccharide in vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 2008, 51, 71-77.
134. Liu, X.; Qu, D.; He, F.; Lu, Q.; Wang, J.; Cai, D. Effect of lycopene on the vascular endothelial function and expression of inflammatory agents in hyperhomocysteinemic rats. Asia. Pac. J. Clin. Nutr., 2007, 16, 244-248.
135. Hu, M.Y.; Li, Y.L.; Jiang, C.H.; Liu, Z.Q.; Qu, S.L.; Huang, Y.M. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits, Nutrition, 2008, 24, 1030-1038.
136. Napolitano, M.; De Pascale, C.; Wheeler-Jones, C.; Botham, K.M.; Bravo, E. Effects of lycopene on the induction of foam cell formation by modified LDL. Am. J. Physiol. Endocrinol. Metab., 2007, 293, 1820-1827.
137. Jacob, K.; Periago, M.J.; Böhm, V.; Berruezo, G.R. Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br. J. Nutr., 2008, 99, 1137-1146.
138. Bessler, H.; Salman, H.; Bergman, M.; Alcalay, Y.; Djaldetti, M. In vitro effect of lycopene on cytokine production by human peripheral blood mononuclear cells. Immunol. Invest., 2008, 37, 183-190.
139. Zefferino, R.; Leone, A.; Piccaluga, S.; Cincione, R.; Ambrosi, L. Mercury modulates interplay between IL-1beta, TNF-alpha, and gap junctional intercellular communication in keratinocytes. mitigation by lycopene. J. Immunotoxicol., 2008, 5, 353-360.
140. Albelda, S.M.; Smith, C.W.; Ward, P.A. Adhesion molecules and inflammatory injury. FASEB J., 1994, 8, 504-512.
141. Frenette, P.S.; Wagner, D.D. Adhesion molecules. Part I. N. Engl. J. Med., 1996, 334, 1526-1529.
142. Roy, S.; Sen, C.K.; Packer, L. Determination of cell-cell adhesion in response to oxidants and antioxidants. In: Methods in Enzymology. Oxidants and Antioxidants. San Diego, CA. Academic, 1999, pp. 395-401.
143. Sellak, H.; Franzini, E.; Hakim, J.; Pasquier C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood, 1994, 83, 2669-2677.
144. Roy, S.; Sen, C.K.; Gozin, A.; Andrieu, V.; Pasquier, C. Redox regulation of cell adhesion processes. In. Antioxidants and Redox Regulation of Genes, Sen, K., Sies, H., Baeuerle, P., Eds. Academic Press: San Diego, 2000, pp. 265-295.
145. FAK a structurally distinctive protein- tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA, 1992, 89, 5192-5196.
146. Hung, C.F.; Huang, T.F.; Chen, B.H.; Shieh, J.M.; Wu, P.H.; Wu, W.B. Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Eur. J. Pharmacol., 2008, 586, 275-282.
147. Gianetti, J.; Pedrinelli, R.; Petrucci, R.; Lazzerini, G.; De Caterina, M.; Bellomo, G.; De Caterina, R. Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am. Heart J., 2002, 143, 467-474.
148. Blum, A.; Monir, M.; Khazim, K.; Peleg, A.; Blum, N. Tomatorich (Mediterranean) diet does not modify inflammatory markers. Clin. Invest. Med., 2007, 30, 70-74.
149. Balestrieri, M.L.; De Prisco, R.; Nicolaus, B.; Pari, P.; Moriello, V.S.; Strazzullo, G.; Iorio, E.L.; Servillo, L.; Balestrieri, C. Lycopene in association with alpha-tocopherol or tomato lipophilic extracts enhances acyl-platelet activating factor biosynthesis in endothelial cells during oxidative stress. Free Rad. Biol. Med., 2004, 36, 1058-1067.
150. Sundl, I.; Roob, J.M.; Meinitzer, A.; Tiran, B.; Khoschsorur, G.; Haditsch, B.; Holzer, H.; Winklhofer-Roob, B.M. Antioxidant status of patients on peritoneal dialysis. associations with inflammation and glycoxidative stress. Perit. Dial. Int., 2009, 29, 89-101.
151. Riccioni, G.; D'Orazio, N.; Palombo, N.; Bucciarelli, V.; Ilio, E.; Bazzano, L.A.; Bucciarelli, T. Relationship between plasma antioxidant concentrations and carotid intima-media thickness. the asymptomatic carotid atherosclerotic disease in manfredonia study. Eur. J. Cardiovasc. Prev. Rehabil., 2009, 16, 351-357.
152. Wang, L.; Gaziano, J.M.; Norkus, E.P.; Buring, J.E.; Sesso, H.D. Associations of plasma carotenoids with risk factors and biomarkers related to cardiovascular disease in middle-aged and older women. Am. J. Clin. Nutr., 2008, 88, 747-54.
153. Leung, E.Y.; Crozier, J.E.; Talwar, D.; O'Reilly, D.S.; McKee, R.F.; Horgan, P.G.; McMillan, D.C. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int. J. Cancer, 2008, 123, 2460-2464.
154. De Pablo, P.; Dietrich, T.; Karlson, E.W. Antioxidants and other novel cardiovascular risk factors in subjects with rheumatoid arthritis in a large population sample. Arthritis Rheum., 2007, 57, 953-962.
155. Hozawa, A.; Jacobs, D.R. Jr; Steffes, M.W.; Gross, M.D.; Steffen, L.M.; Lee, D.H. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction. the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) study. Clin. Chem., 2007, 53, 447-455.
156. Walston, J.; Xue, Q.; Semba, R.D.; Ferrucci, L.; Cappola, A.R.; Ricks, M.; Guralnik, J.; Fried, L.P. Serum antioxidants, inflammation, and total mortality in older women. Am. J. Epidemiol., 2006, 163, 18-26.
157. Almushatat, A.S.; Talwar, D.; McArdle, P.A.; Williamson, C.; Sattar, N.; O'Reilly, D.S.; Underwood, M.A.; McMillan, D.C. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int. J. Cancer, 2006, 118, 1051-1053.
158. Chang, C.Y.; Chen, J.Y.; Ke, D.; Hu, M.L. Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients. correlation to inflammation markers and neurological deficits. Nutrition., 2005, 21, 987-993.
159. Pattison, D.J.; Symmons, D.P.; Lunt, M.; Welch, A.; Bingham, S.A.; Day, N.E.; Silman, A.J. Dietary beta-cryptoxanthin and inflammatory polyarthritis. results from a population-based prospective study. Am. J. Clin. Nutr., 2005, 82, 451-455.
160. Sesso, H.D.; Buring, J.E.; Norkus, E.P.; Gaziano, J.M. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. Am. J. Clin. Nutr., 2005, 81, 990-997.
161. Van Herpen-Broekmans, W.M.; Klöpping-Ketelaars, I.A.; Bots, M.L.; Kluft, C.; Princen, H.; Hendriks, H.F.; Tijburg, L.B.; van Poppel, G.; Kardinaal, A.F. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur. J. Epidemiol., 2004, 19, 915-921.
162. Ford, E.S.; Liu, S.; Mannino, D.M.; Giles, W.H.; Smith, S.J. Creactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur. J. Clin. Nutr., 2003, 57, 1157-1163.
163. Quasim, T.; McMillan, D.C.; Talwar, D.; Sattar, N.; O'Reilly, D.S.; Kinsella, J. Lower concentrations of carotenoids in the critically ill patient are related to a systemic inflammatory response and increased lipid peroxidation. Clin. Nutr., 2003, 22, 459-462.
164. Jonasson, L.; Wikby, A.; Olsson, A,G. Low serum beta-carotene reflects immune activation in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis., 2003, 13, 120-125.
165. Rowley, K.; Walker, K.Z.; Cohen, J.; Jenkins, A.J.; O'Neal, D.; Su, Q.; Best, J.D.; O'Dea, K. Inflammation and vascular endothelial activation in an Aboriginal population. relationships to coronary disease risk factors and nutritional markers. Med. J. Aust., 2003, 178, 495-500.
166. McMillan, D.C.; Talwar, D.; Sattar, N.; Underwood, M.; O'Reilly, D.S.; McArdle, C. The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin. Nutr., 2002, 21, 161-164.
167. Rissanen, T.; Voutilainen, S.; Nyyssönen, K.; Salonen, R.; Salonen, J.T. Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 2677-2681.
168. D'Odorico, A.; Martines, D.; Kiechl, S.; Egger, G.; Oberhollenzer, F.; Bonvicini, P.; Sturniolo, G.C.; Naccarato, R.; Willeit, J. High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis. results from the Bruneck study. Atherosclerosis, 2000, 153, 231-239.
169. Kritchevsky, S.B.; Bush, A.J.; Pahor, M.; Gross, M.D. Serum carotenoids and markers of inflammation in nonsmokers. Am. J. Epidemiol., 2000, 15, 1065-1071.
170. De Beaux, A.C.; Ross, J.A.; Maingay, J.P.; Fearon, K.C.; Carter, D.C. Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br. J. Surg., 1996, 83, 1071-1075.
171. McGrath, L.T.; Mallon, P.; Dowey, L.; Silke, B.; McClean, E.; McDonnell, M.; Devine, A.; Copeland, S.; Elborn, S. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax., 1999, 54, 518-523.
172. Goodman, M.T.; Shvetsov, Y.B.; McDuffie, K.; Wilkens, L.R.; Zhu, X.; Franke, A.A.; Bertram, C.C.; Kessel, B.; Bernice, M.; Sunoo, C.; Ning, L.; Easa, D.; Killeen, J.; Kamemoto, L.; Hernandez, B.Y. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res., 2007, 67, 5987-5996.
173. van der Horst-Graat, J.M.; Kok, F.J.; Schouten, E.G. Plasma carotenoid concentrations in relation to acute respiratory infections in elderly people. Br. J. Nutr., 2004, 92, 113-118.
174. Cser, M.A.; Majchrzak, D.; Rust, P.; Sziklai-László, I.; Kovács, I.; Bocskai, E.; Elmadfa, I. Serum carotenoid and retinol levels during childhood infections. Ann. Nutr. Metab., 2004, 48, 156-162.
175. Sedjo, R.L.; Papenfuss, M.R.; Craft, N.E.; Giuliano, A.R. Effect of plasma micronutrients on clearance of oncogenic human papillomavirus (HPV) infection (United States). Cancer Causes Control., 2003, 14, 319-326.
176. Lan, Y.; Kumwenda, N.; Taha, T.E.; Chiphangwi, J.D.; Miotti, P.G.; Mtimavalye, L.; Broadhead, R.; van der Hoeven, L.; Hoover, D.R.; Semba, R.D. Carotenoid status of pregnant women with and without HIV infection in Malawi. East Afr. Med. J., 1999, 76, 133-137.
177. Riso, P.; Visioli, F.; Grande, S.; Guarnieri, S.; Gardana, C.; Simonetti, P.; Porrini, M. Effect of a tomato-based drink on markers of inflammation, immunomodulation, and oxidative stress. J. Agric. Food Chem., 2006, 54, 2563-2566.
178. Upritchard, J.E.; Sutherland, W.H.; Mann, J.I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care., 2000, 23, 733-38.
179. Watzl, B.; Bub, A.; Blockhaus, M.; Herbert, B.M.; Lührmann, P.M.; Neuhäuser-Berthold, M.; Rechkemmer, G. Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J. Nutr., 2000, 130, 1719-1723.
180. Denniss, S.G.; Haffner, T.D.; Kroetsch, J.T.; Davidson, S.R.; Rush, J.W.; Hughson, R.L. Effect of short-term lycopene supplementation and postprandial dyslipidemia on plasma antioxidants and biomarkers of endothelial health in young, healthy individuals. Vasc. Health Risk. Manag., 2008, 4, 213-222.
181. Blum, A.; Monir, M.; Khazim, K.; Peleg, A.; Blum, N. Tomatorich (Mediterranean) diet does not modify inflammatory markers. Clin. Invest. Med., 2007, 30, 70-74.